These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2804743)

  • 1. [Immunologic characteristics of serum CuZn-superoxide dismutase in cancer patients].
    Shen WM
    Zhonghua Yi Xue Za Zhi; 1989 May; 69(5):286-7. PubMed ID: 2804743
    [No Abstract]   [Full Text] [Related]  

  • 2. [Observations on the activity and immunologic properties of CuZn-SOD of whole blood in cancer patients].
    Liu ZF; Fang YZ
    Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):212-3. PubMed ID: 2776063
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunologic changes in serum CuZn-containing superoxide dismutase in patients with lung cancer].
    Zhou D; Tian YP; He ZQ
    Zhonghua Nei Ke Za Zhi; 1989 Jul; 28(7):421-2, 445. PubMed ID: 2556249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antigen-antibody reaction between anti-bovine CuZn-SOD antisera and CuZn-SOD in the blood of cancer patients].
    Fang YZ; Liu ZF
    Zhonghua Yi Xue Za Zhi; 1987 Jun; 67(6):351-2. PubMed ID: 3115542
    [No Abstract]   [Full Text] [Related]  

  • 5. Distribution of CuZn superoxide dismutase and Mn superoxide dismutase in human tissues and extracellular fluids.
    Marklund S
    Acta Physiol Scand Suppl; 1980; 492():19-23. PubMed ID: 6939305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of chemotherapy on circulating angiogenic factor levels in patients with breast cancer].
    Tang JH; Zhao JH; Gong JP; Qin JW; Pan LQ; Xu ZY
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):210-4. PubMed ID: 17649639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antioxidant status of patients with primary colorectal cancer and liver metastases of colorectal cancer].
    Czeczot H; Skrzycki M; Podsiad M; Gawryszewska E; Nyckowski P; Porembska Z
    Pol Merkur Lekarski; 2005 Jan; 18(103):58-61. PubMed ID: 15859549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) detection in cancer patients: a prognostic marker for lung metastases from solid malignancies.
    Karapanagiotou EM; Pelekanou E; Charpidou A; Tsaganos T; Anagnostou V; Plachouras D; Giamarellos-Bourboulis EJ; Syrigos KN
    Anticancer Res; 2008; 28(2B):1411-5. PubMed ID: 18505088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum midkine levels are increased in patients with various types of carcinomas.
    Ikematsu S; Yano A; Aridome K; Kikuchi M; Kumai H; Nagano H; Okamoto K; Oda M; Sakuma S; Aikou T; Muramatsu H; Kadomatsu K; Muramatsu T
    Br J Cancer; 2000 Sep; 83(6):701-6. PubMed ID: 10952771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma amino acid imbalance in patients with lung and breast cancer.
    Cascino A; Muscaritoli M; Cangiano C; Conversano L; Laviano A; Ariemma S; Meguid MM; Rossi Fanelli F
    Anticancer Res; 1995; 15(2):507-10. PubMed ID: 7763031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombin III profiles in malignancy, relationship primary tumors and metastatic sites.
    Honegger H; Anderson N; Hewitt LA; Tullis JL
    Thromb Haemost; 1981 Aug; 46(2):500-3. PubMed ID: 7302888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Calcitonin. III. Use of serum calcitonin as a tumor marker in breast and pulmonary neoplasms].
    Gadesberg CC; Nielsen HE; Olsen KJ; Hansen HH
    Ugeskr Laeger; 1979 Oct; 141(40):2744-6. PubMed ID: 531963
    [No Abstract]   [Full Text] [Related]  

  • 13. [Relationship of serum level of creatine kinase of MB type to cardiac function of patients with advanced tumors and its prognostic value].
    Wu XM; Hu CZ; Li N; Zhu JQ; Wu YF
    Ai Zheng; 2005 Apr; 24(4):506-8. PubMed ID: 15820080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutathione peroxidase, glutathione-S-transferase, catalase, xanthine oxidase, Cu-Zn superoxide dismutase activities, total glutathione, nitric oxide, and malondialdehyde levels in erythrocytes of patients with small cell and non-small cell lung cancer.
    Kaynar H; Meral M; Turhan H; Keles M; Celik G; Akcay F
    Cancer Lett; 2005 Sep; 227(2):133-9. PubMed ID: 16112416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of cancer procoagulant (CP) in serum of patients with cancer of lung, breast, oesophagus and colorectum.
    Rucińska M; Furman M; Skrzydlewski Z; Zaremba E
    Acta Biochim Pol; 1997; 44(1):109-12. PubMed ID: 9241361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical investigation of erythrocyte function in patients with lung cancer].
    Zhang YX; Zhang YG
    Zhonghua Jie He He Hu Xi Za Zhi; 1993 Oct; 16(5):278-80, 319. PubMed ID: 7923431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatocyte growth factor in the sera of patients with gastrointestinal and breast cancer].
    Narita T; Toi M; Sekiguchi K; Iwanari H; Matsuura N; Kimura N; Mitsuoka C; Kannagi R
    Gan To Kagaku Ryoho; 1997 Nov; 24(14):2159-62. PubMed ID: 9388530
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma and erythrocyte total antioxidant status in patients with benign and malign breast disease.
    Afrasyap L; Güvenen G; Türkmen S
    Cancer Biochem Biophys; 1998 Jun; 16(1-2):129-38. PubMed ID: 9923972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudouridine determination in blood serum as tumor marker.
    Salvatore F; Russo T; Colonna A; Cimino L; Mazzacca G; Cimino F
    Cancer Detect Prev; 1983; 6(6):531-6. PubMed ID: 6318996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variations of zinc, calcium and magnesium in normal subjects and in patients with neoplasias.
    Chirulescu Z; Chiriloiu C; Suciu A; Pîrvulescu R
    Med Interne; 1987; 25(4):257-61. PubMed ID: 3423702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.